Correvio Pharma Corp (CORV.CA) Stock Price & Overview

TSX:CORV

0.56
0 (0%)
Last: May 29, 2020, 03:31 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of CORV.CA is 0.56 null. Today CORV.CA is down by 0%. In the past month the price increased by 1.82%. In the past year, price decreased by -81.33%.

CORV.CA Key Statistics

52-Week Range0.36 - 3.66
Current CORV.CA stock price positioned within its 52-week range.
1-Month Range0.53 - 0.6
Current CORV.CA stock price positioned within its 1-month range.
Market Cap
37.068M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.79
Dividend Yield
N/A

CORV.CA Stock Performance

Today
0%
1 Week
-5.08%
1 Month
+1.82%
3 Months
-9.68%
Longer-term
6 Months -79.64%
1 Year -81.33%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

CORV.CA Stock Chart

Correvio Pharma Corp / CORV Daily stock chart

CORV.CA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to CORV.CA. When comparing the yearly performance of all stocks, CORV.CA is a bad performer in the overall market: 92.21% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
CORV.CA Full Technical Analysis Report

CORV.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CORV.CA. CORV.CA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CORV.CA Full Fundamental Analysis Report

CORV.CA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
CORV.CA Earnings History

CORV.CA Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-10.13%
Revenue Next YearN/A
CORV.CA Forecast & Estimates

CORV.CA Financial Highlights

Over the last trailing twelve months CORV.CA reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS decreased by -68.09% compared to the year before.


Income Statements
Revenue(TTM)32.63M
Net Income(TTM)-35.18M
Industry RankSector Rank
PM (TTM) -107.81%
ROA -59.74%
ROE N/A
Debt/Equity -32.66
Chartmill High Growth Momentum
EPS Q2Q%61.11%
Sales Q2Q%26.59%
EPS 1Y (TTM)-68.09%
Revenue 1Y (TTM)13.81%
CORV.CA financials

CORV.CA Ownership

Ownership
Inst Owners5.18%
Shares66.19M
FloatN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
CORV.CA Ownership

About CORV.CA

Company Profile

Correvio Pharma Corp, formerly Cardiome Pharma Corp is a specialty pharmaceutical company. It is engaged in the development and commercialization of cardiovascular therapies. The company's products include AGGRASTAT, EXEMBOL, BRINAVESS and others.

Company Info

Correvio Pharma Corp

1441 Creekside Drive

Vancouver BC V6J 4S7

CEO: William L. Hunter

Phone: +1 604 677-6905

Correvio Pharma Corp / CORV.CA FAQ

Can you describe the business of Correvio Pharma Corp?

Correvio Pharma Corp, formerly Cardiome Pharma Corp is a specialty pharmaceutical company. It is engaged in the development and commercialization of cardiovascular therapies. The company's products include AGGRASTAT, EXEMBOL, BRINAVESS and others.


What is the current price of CORV stock?

The current stock price of CORV.CA is 0.56 null.


Does Correvio Pharma Corp pay dividends?

CORV.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of CORV stock?

CORV.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Should I buy CORV stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CORV.CA.


What is Correvio Pharma Corp worth?

Correvio Pharma Corp (CORV.CA) has a market capitalization of 37.07M null. This makes CORV.CA a Nano Cap stock.